Philips Receives FDA Approval for Zenition 30 Mobile C-arm

Royal Philips has received US FDA 510(k) clearance of Zenition 30 mobile C-arm, making image-guided surgical procedures available to more US patients at a lower cost.

By giving surgeons greater flexibility, control, and personalization of C-arm movement and user settings, Zenition 30 reduces the number of support staff required during procedures, addressing the budgetary constraints that plague many of today’s hospital systems. The enhanced workflow efficiency offered by intuitive C-arm control from alongside the patient table means that surgeons can treat more patients yet also spend more time focusing on each patient, leading to a better patient and staff experience.

The new Zenition 30 offers a unique combination of personalized control and image clarity to enhance the speed and accuracy of decision making for a range of clinical procedures at a price point that meets today’s economic and business goals,” said Mark Stoffels, General Manager Philips Image Guided Therapy Systems.

To view the source version, please click HERE.

en_GBEnglish (UK)